-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Elevation Oncology Halts Investment in Seribantumab; Plans 30% Workforce Cut; CEO Shawn Leland Resigns

Elevation Oncology Halts Investment in Seribantumab; Plans 30% Workforce Cut; CEO Shawn Leland Resigns

MT Newswires · 01/06/2023 05:01